Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
Br J Cancer
; 120(5): 512-521, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30765873
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proto-Oncogene Proteins
/
Receptor Protein-Tyrosine Kinases
/
Carcinoma, Hepatocellular
/
Drug Resistance, Neoplasm
/
Sorafenib
/
Liver Neoplasms
/
Antineoplastic Agents
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2019
Type:
Article
Affiliation country:
United kingdom